Doxazosin
- Product NDC
- 43063-739
- 11-digit product format
- 430630739
- Labeler code
- 43063
- Product ID
- 43063-739_51b5d78a-4dbf-f9ca-e063-6394a90a840a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Doxazosin
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- PD-Rx Pharmaceuticals, Inc.
- Application
- ANDA075580
- Marketing category
- ANDA
- Marketing start
- 2011-07-14
- Substance
- DOXAZOSIN MESYLATE
- Active strength
- 2 mg/1
- Pharmacologic classes
- Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Doxazosin
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| DOXAZOSIN MESYLATE | 2 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 86P6PQK0MU |
| Rxcui | 197626 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 43063-739-90 | Doxazosin | 90 in 1 BOTTLE, PLASTIC | TABLET | 90 | | 21 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 43063-739 | DOXAZOSIN TABLET [PD-RX PHARMACEUTICALS, INC.] | 19 | Current NDC, Legacy NDC, 1 package rows | 20240925_2ea9bb6b-a4f0-496a-b27b-4454167a4b70.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 43063-739-90 | 43063073990 | 90 TABLET in 1 BOTTLE, PLASTIC (43063-739-90) | 90 tablet | 2017-01-31 | 0000-00-00 | No | No | Current |